A STUDY TO EVALUATE BIOMARKERS OF SENSITIVITY AND RESISTANCE IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA WHO ARE TREATED WITH BRENTUXIMAB VEDOTIN - Regional Cancer Care Associates LLC

Clinical Trials

A STUDY TO EVALUATE BIOMARKERS OF SENSITIVITY AND RESISTANCE IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA WHO ARE TREATED WITH BRENTUXIMAB VEDOTIN

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Seattle Genetics
Protocol Number
Seattle Genetics SGN35-018
Cancer Diagnosis
To Learn More Call
201-510-0910